After mutagenesis with nitrosoguanidine and selection by immuno-halo techniques, an avirulent mutant, designated Texas Star-SR, which produces no detectable A (active; ADP-ribosylating) region of the cholera enterotoxin (choleragen) but produces the B region (choleragenoid) in amounts similar to the hypertoxinogenic wild-type parent Vibrio cholerae (biotype El Tor serotype Ogawa), has been isolated. The mutant retains the colonizing ability, motility, prototrophy, and serologic characteristics of the parent. In relevant intestinal experimental models, it has been shown to be avirulent and to induce protection against challenge with virulent cholera vibrios. The mutant appears to be suitable for further evaluation in volunteers as a candidate living enteric vaccine against cholera and related enterotoxic enteropathies. Cholera is the prototype of an increasing number of newly recognized diarrheal diseases, enterotoxic enteropathies, which depend on soluble enterotoxins, some of which are related to the cholera enterotoxin (choleragen), both immunologically and by mode of action (1). Perhaps because of its intestinal locus, conventional cholera vaccines composed of killed bacteria, administered parenterally, are relatively ineffective in preventing cholera (2). However, the disease itself is an immunizing process (3). Further, a perorally administered hypotoxinogenic Vibrio cholerae mutant, M13 (4), was found to be avirulent for human beings and to induce substantial immunity against subsequent challenge with virulent cholera vibrios (5, 6). Because of its limited production of toxin antigen, M13 would offer little, if any, protection against other enterotoxic enteropathies. Because it also appeared to be unstable (5, 6), further evaluation of M13 as a vaccine was contra-indicated.Choleragen is a polymeric protein consisting of noncovalently associated subunits (7), of which the A region is responsible for activation of adenylate cyclase and the B region (choleragenoid), which has been shown to be highly immunogenic, is responsible for binding of the holotoxin to host cell membrane receptors, thereby facilitating entry of the A region (8-11). Thus an A-B+ V. cholerae mutant could be predicted to be avirulent and capable of stimulating local immunity against cholera and the immunologically related enterotoxins that share B-related antigens. The potential value of such a mutant was postulated earlier (12). The isolation and characterization of such an A-B+ mutant, which appears to be stable, is described in this report.
METHODSV. cholerae Strains. Two hypertoxinogenic strains of V. cholerae were used. The first, V. cholerae 569B, a classical vibrio of the Inaba serotype, has been widely used by us and by others for production of choleragen and in genetic studies (4,(13)(14)(15)(16). The other was 3083, an El Tor biotype Ogawa serotype, isolated by one of us (R.A.F.) from a patient in Vietnam in 1964 (17), which has been shown to be highly adherent in infant rabbits (18). All strains and mutants were maintai...